-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Agios Pharmaceuticals, Lowers Price Target to $30

Benzinga·11/20/2026 17:52:02
JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and lowers the price target from $34 to $30.